"10.1371_journal.pone.0031071","plos one","2012-02-17T00:00:00Z","Xiaoxia Z West; Nahum Meller; Nikolay L Malinin; Lalit Deshmukh; Julia Meller; Ganapati H Mahabeleshwar; Malory E Weber; Bethany A Kerr; Olga Vinogradova; Tatiana V Byzova","Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; University Hospitals Harrington-McLaughlin Heart & Vascular Institute and Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America","Conceived and designed the experiments: OV TVB NM LD GHM. Performed the experiments: NM LD XZW JM GHM MEW BAK. Analyzed the data: XZW NM LD NLM GHM OV TVB. Wrote the paper: ZZW NM LD NLM BAK OV TVB.","A patent suggesting the utilization of integrin derived peptides for anti-angiogenesis treatment (Cleveland Clinic Foundation) is pending. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","02","Xiaoxia Z West","XZW",10,TRUE,5,7,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
